EUVIMEDEUVIMED entdecken
Open Access

Evaluating the benefits of a second pain treatment following a clinical trial.

Tracy M Anastas iD, Aaron P Turner iD, Erica J Ho iD, Melissa A Day iD, Dawn M Ehde iD, Mark P Jensen iD, Rhonda M Williams iD

Rehabilitation Psychology · 2024

DOI: 10.1037/rep0000510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rehabilitation Psychology, 2024. Verfasst von Tracy M Anastas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Care Service, VA Puget Sound Health Care System. Hauptthemen laut MEDLINE: Chronic Pain, Veterans. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS, NIMH NIH HHS, National Center for Complementary and Integrative Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To examine the value of including an open label phase after a clinical trial of pain treatments by examining participant characteristics and potential benefits. METHOD: Secondary data analysis. Veterans with chronic pain who completed a randomized controlled trial (RCT) comparing hypnosis, mindfulness meditation, and pain education were invited to participate in an open label phase. Average and worst pain intensities, pain interference, and depression were assessed pre- and postopen label phase; global impressions of change and treatment satisfaction were assessed at postopen label phase only. RESULTS: Of those who were offered the open label phase, 40% (n = 68) enrolled. Enrollees were likely to be older, to have attended more sessions in the RCT, to be satisfied with their first treatment, and to perceive improvement in their ability to manage pain after the RCT. In the open label phase, depression and worst pain decreased across all three treatment conditions. No other improvements were observed. However, most Veterans perceived improvements in pain intensity, ability to manage pain, and pain interference, and were satisfied with the second intervention. CONCLUSIONS: There appears to be some value to adding an open label phase to the end of a trial of pain treatments. A substantial portion of study participants elected to participate and reported it to be beneficial. Exploring data from an open label phase can illuminate important aspects of patient experience, barriers to and facilitators of care, as well as treatment preferences. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainVeteransHumansPain ManagementTreatment OutcomeRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Rehabilitation Care Service, VA Puget Sound Health Care System.
  • Department of Rehabilitation Medicine, University of Washington School of Medicine.

ORCID-Profile: Tracy M Anastas, Aaron P Turner, Erica J Ho, Melissa A Day, Dawn M Ehde, Mark P Jensen, Rhonda M Williams

Förderung

  • NCCIH NIH HHS
  • NIMH NIH HHS
  • National Center for Complementary and Integrative Health
  • VA Puget Sound Health Care System
  • University of Washington
  • National Institute of Mental Health

Zitieren

APA

Anastas, T. M., Turner, A. P., Ho, E. J., Day, M. A., Ehde, D. M., Jensen, M. P., & Williams, R. M. (2024). Evaluating the benefits of a second pain treatment following a clinical trial. Rehabilitation Psychology. https://doi.org/10.1037/rep0000510

Vancouver

Anastas TM, Turner AP, Ho EJ, Day MA, Ehde DM, Jensen MP, et al. Evaluating the benefits of a second pain treatment following a clinical trial. Rehabilitation Psychology. 2024. doi:10.1037/rep0000510

BibTeX
@article{Anastas2024,
  author = {Anastas, Tracy M and Turner, Aaron P and Ho, Erica J and Day, Melissa A and Ehde, Dawn M and Jensen, Mark P and Williams, Rhonda M},
  title = {Evaluating the benefits of a second pain treatment following a clinical trial},
  journal = {Rehabilitation Psychology},
  year = {2024},
  doi = {10.1037/rep0000510}
}
Kostenlos starten →